Spectroscopic and electrochemical characterizations of copper complexes with thionine, azure C and azure A

Structures held together by secondary interactions such as intramolecular or intermolecular hydrogen bonding, electrostatic and π–π interaction without covalent bonds can exhibit new properties such as high orientation, optoelectronics, biocompatibility and reversibility (self-renewal). Recently, interest has been growing surrounding novel molecules fashioned through non-covalent interactions. These molecules have garnered attention due to their significant roles in both physical and chemical applications. However, the formation of complexes between cationic phenothiazine derivative dyes, commonly employed in electrochemical studies, and diverse metal groups presents a challenge. Therefore, the existing literature contains only a scant number of studies concerning the formation of phenothiazine complexes with metal salts. In this study, metal complexes of thionine, azure C and azure A with copper(II) chloride were prepared using two steps: dissolving and then slow evaporation of dyes-copper(II) chloride in acetonitrile. Besides the theoretical computations, thermal, spectral, electrochemical and fluorescence techniques were performed to determine the characteristics of the monoclinic crystals of Cu–dyes complexes. Cl− ion in the dyes and copper(II) chloride conjugated to form [CuCl3]−, then this anion electrostatically bound to cationic phenothiazine ring bond to be phenothiazine+[CuCl3]−. Cu–dye complexes showed interestingly high electron transportation. In addition, prepared Cu–dye complexes have a great potential to be used in optical and spectral applications with extraordinary behaviour of their spectral and fluorescence features

Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein

Background: Optic neuritis, myelitis, and neuromyelitis optica spectrum disorder (NMOSD) have been associated with antibodies against myelin oligodendrocyte glycoprotein-immunoglobulin G (anti-MOG-IgG). Furthermore, patients with radiological and demographic features atypical for multiple sclerosis (MS) with optic neuritis and myelitis also demonstrate antibodies against aquaporin-4 and anti-MOG-IgG. However, data on the diagnosis, treatment, follow-up, and prognosis in patients with anti-MOG-IgG are limited. Aims: To evaluate the clinical, radiological, and demographic characteristics of patients with anti-MOG-IgG. Study Design: Multicenter, retrospective, observational study. Methods: Patients with blood samples demonstrating anti-MOG-IgG that had been evaluated at the Neuroimmunology laboratory at Ondokuz Mayıs University’s Faculty of Medicine were included in the study. Results: Of the 104 patients with anti-MOG-IgG, 56.7% were women and 43.3% were men. Approximately 2.4% of the patients were diagnosed with MS, 15.8% with acute disseminated encephalomyelitis (ADEM), 39.4% with NMOSD, 31.3% with isolated optic neuritis, and 11.1% with isolated myelitis. Approximately 53.1% of patients with spinal involvement at clinical onset demonstrated a clinical course of NMOSD. Thereafter, 8.8% of these patients demonstrated a clinical course similar to MS and ADEM, and 28.1% demonstrated a clinical course of isolated myelitis. The response to acute attack treatment was lower and the disability was higher in patients aged > 40 years than patients aged < 40 years at clinical onset. Oligoclonal band was detected in 15.5% of the patients. Conclusion: For patients with NMOSD and without anti-NMO antibodies, the diagnosis is supported by the presence of anti-MOG-IgG. Furthermore, advanced age at clinical onset, Expanded Disability Status Scale (EDSS) score at clinical onset, spinal cord involvement, and number of attacks may be negative prognostic factors in patients with anti-MOG-IgG